Ignite Creation Date:
2024-05-06 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03527147
Status:
COMPLETED
Last Update Posted:
2022-08-15
First Post:
2018-04-24
Brief Title:
Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkins Lymphoma PRISM Study
Sponsor:
Acerta Pharma BV
Organization:
Acerta Pharma BV
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-19
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-24
First Submit QC Date:
May 16 2018
Study First Post Date:
2018-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-11
Last Update Post Date:
2022-08-15
Last Update Post Date Type:
ACTUAL